William J. Link Ph.D., Director at Oyster Point Pharma, Inc. (OYST), sold 1,096,557 shares at $15.09 ($16.3M) on 2021-10-18, disclosed to the SEC on 2021-10-20.
Open-market sale of $16.3M OYST by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.63 | 1,912 | $28K | 0.2% |
| 2 | $14.63 | 303,614 | $4.4M | 27.3% |
| 3 | $14.63 | 303,614 | $4.4M | 27.3% |
| 4 | $15.09 | 1,531 | $23K | 0.1% |
| 5 | $15.09 | 242,943 | $3.7M | 22.5% |
| 6 | $15.09 | 242,943 |
| $3.7M |
| 22.5% |
| Total | $14.83 avg | 1,096,557 | $16.3M | 100% |
| Filing → |
| TARS | SELL | 2026-03-18 | $860K | — | Filing → |
| TARS | SELL | 2025-12-17 | $3.3M | — | Filing → |
| TARS | SELL | 2025-09-10 | $1.5M | — | Filing → |